Swiss pharmaceutical company Roche announced net income was down but it expects mid single-digit sales increase for 2024. Roche reported that its International Financial Reporting Standards (IFRS) net income for fiscal year 2023 declined about 9% to 12.36 billion Swiss francs from 13.53 billion francs last year. But IFRS net income increased by 7% at constant exchange rates (CER) due to the increase in operating profit and lower income tax expenses. Core earnings per share was 18.57 francs down
(Reuters) -Renault on Wednesday reported a 9% increase in annual global sales volumes for 2023, returning to growth after four consecutive years of decline and the French automaker said it was poised to continue its strong performance in 2024. Renault's sales slump was exacerbated by its exit from the Russian market. To boost sales, Renault shrank its vehicle range and refocused under CEO Luca de Meo on its most profitable markets and models.